Analysis of the TP53 exon 4 gene polymorphism in patients with oral squamous cell carcinoma
Análise do polimorfismo no gene TP53 éxon 4 em pacientes com carcinoma de células escamosas oral
DOI:
https://doi.org/10.53660/CLM-3839-23P05Palavras-chave:
Oral cancer, Genetic polymorphism, p53 gene, Squamous cell carcinomaResumo
Squamous cell carcinoma (SCC) of the oral cavity is the most frequent epithelial neoplasm among head and neck cancers, with multifactorial etiology. Risk factors include smoking, alcohol consumption, and genetic predisposition. The p53 gene, known as the guardian of the genome, has a polymorphism at codon 72 of exon 4, resulting in the arginine/proline genotype. This case-control study included 280 healthy individuals and eight patients with oral SCC treated at a reference hospital in Brasília. Using PCR-RFLP, we investigated the association between the p53 Arg72Pro polymorphism (rs1042522) and oral SCC. A statistically significant predominance of the Arg/Arg genotype was observed in the case group (p=0.004). The results suggest that the Arg/Arg genotype may be associated with an increased risk of developing oral SCC. It is concluded that, although promising, studies with larger samples are needed to validate this polymorphism as a predictive marker.
Downloads
Referências
AHMED, S., et al. Prevalence of TP53 gene Pro72Arg (rs1042522) single nucleotide polymorphism among Egyptian breast cancer patients. Egypt J Med Hum Genet 24, 24. 2023.
AL-KOOFEE, DAF; MUBARAK, SMH. Genetic polymorphisms. In: The Recent Topics in Genetic Polymorphisms. London: IntechOpen. 2020.
ARRUDA, JT.; BORDIN, BM; MIRANDA, LCB; MAIA, DLM.; MOURA, KKVO –Proteína p53 e o câncer: controvérsias e esperança. Estudos, Goiânia, v. 35, n. 1/2, p. 123-141, jan./fev. 2008.
CHAKROBARTY B, ROY JG, MAJUMDAR S, UPPALA D. Relationship among tobacco habits, human papilloma virus (HPV) infection, p53 polymorphism/mutation and the risk of oral squamous cell carcinoma. J Oral Maxillofac Pathol. 18(2):211-216. 2014.
COARACY, AEV et al. Correlação entre os dados clínicos e histopatológicos dos casos de carcinoma espinocelular oral do Instituto Maranhense de Oncologia Aldenora Bello, em São Luís, MA. Jornal Brasileiro de Patologia e Medicina Laboratorial [online]. v. 44, n. 1, pp. 31-35. 2008.
COSTA, ALL et al. Correlação entre a classificação TNM, gradação histológica e localização anatômica em carcinoma epidermóide oral. Pesquisa Odontológica Brasileira. v. 16, n. 3, pp. 216-220. 2002.
DIAKITE B, KASSOGUE Y, DOLO G, et al. P.Arg72Pro polymorphism of P53 and breast cancer risk: a meta-analysis of case-control studies. BMC Med Genet. 21(1):206. 2020.
GERVÁSIO, OLAS et al. Carcinoma Espinocelular Oral: Estudo Retrospectivo de 740 casos em uma população brasileira. Braz Dent J. 12 (1): 57-61. 2001.
GLOBOCAN. International Agency for Research on Cancer. Geneva: World Health Organization. Disponível em: <https://gco.iarc.fr/>.2024.
HALLIKERI, K et al. p53 polymorphism and association of human papillomavirus in oral submucous fibrosis and oral squamous cell carcinoma: A case-control study. Journal of oral and maxillofacial pathology. vol. 23,1,97-103. 2019.
HANSON, H. et al. UKCGG Consensus Group guidelines for the management of patients with constitutional TP53 pathogenic variants. Journal of Medical Genetics; 58:135-139. 2021.
INSTITUTO NACIONAL DE CÂNCER. Dados e números sobre câncer de mama - Relatório anual 2023. Coordenação de Prevenção e Vigilância, Rio de Janeiro (RJ), INCA, 2023.
JUNIOR, J.C.O. et al. Malefícios do uso do cigarro eletrônico para a cavidade oral - Revisão Integrativa de Literatura. Rev Med (São Paulo). jul-ago.;102(4):e-208929. 2023.
JÚNIOR, JAS. Análise molecular dos genes TP53 e MDM2 em carcinomas de células escamosas de boca. Niterói: UFF, Faculdade de Medicina, 2012.
JUNIOR, JAS; BERNARDO, VG; BALASSIANO, KZ; SOARES, FD; FONSECA, EC; SILVA, LE; LOURENÇO, SQC. Análise comparativa da imunoexpressão da proteína p53 (clones DO-7 e PAb-240) em carcinomas de células escamosas intrabucais e labiais. J Bras Patol Med Lab. v. 45, n. 4, p. 335-342, agosto. 2009.
KRATZ, C.P. et al. Cancer screening recommendations for individuals with Li-Fraumeni syndrome. Clin Cancer Res; 23(11) June 1, 2017.
LEE, YH; RHO, YH; CHOI, SJ; JI, JD; SONG, GG. The functional p53 codon 72 polymorphism is associated with systemic lupus erythematosus. 2005.
LIMA, JM; SERAFIM, PVP; SILVA, IDCG; FORONES, NM. Estudo do polimorfismo
genético no gene p53 (códon 72) em câncer colorretal. Arq Gastroenterol v. 43 – no.1 – jan./mar. 2006.
MARCHIONI, DML et al. Fatores dietéticos e câncer oral: estudo caso-controle na Região Metropolitana de São Paulo, Brasil. Cadernos de Saúde Pública [online].v. 23, n. 3, pp. 553-564. 2007.
MARKOPOULOS, Anastasios K. Currentaspectson oral squamouscell carcinoma. The open dentistry journal, v. 6, p. 126, 2012.
MOJTAHED Z et al. P53 codon 72 polymorphism association with head and neck squamouss cell carcinoma. Braz J Otorhinolaryngol.76(3):316-20. 2010.
OLIVEIRA JUNIOR, JC; et al. Malefícios do uso do cigarro eletrônico para a cavidade oral e para a saúde sistêmica- Revisão Integrativa de Literatura. Revista de Medicina, São Paulo, Brasil, v. 102, n. 4, p. e-208929, 2023.
PERUSSI, M. R. et al Carcinoma epidermóide da boca em idosos de São Paulo. Rev Assoc Med Bras, v. 48, n. 4, p. 341-4, 2002.
ROGHA, M; BERJIS, N; LAJEVARDI, SM; ALAMDARAN, M; HASHEMI, SM. Identificação da mutação R249 no gene P53 no tecido tumoral do câncer de língua. Int J Prev Med; 10:129. 2019.
SALEEM S, AZHAR A, HAMEED A, KHAN MA, ABBASI ZA, QURESHI NR, AJMAL M. P53 (PRO72ARG) polymorphism associated with the risk of oral squamous cell carcinoma in gutka, niswar and manpuri addicted patients of Pakistan. Oral Oncology 49. 818-823. 2013.
SANTOS, JCS et al. Avaliação clínico-epidemiológica de pacientes com carcinoma de células escamosas oral - Revista Brasileira de Cancerologia, 68. 2022.
SUN, Z., GAO, W. & CUI, JT. Efeito do TP53 rs1042522 na suscetibilidade de pacientes ao carcinoma de células escamosas oral e leucoplasia oral: uma meta-análise. BMC Saúde Bucal 18, 143. 2018.
TANDON N, SRIVASTAVA AN, FATIMA N, RAZA ST, KUMAR V. p53 Codon 72 Gene Polymorphism Studies and p53 Expression by Immunohistochemistry in Oral Lesions as Risk Factor for Malignancy. Int J Appl Basic Med Res. 7(4):243-246. 2017.
TEAMA, S. DNA Polymorphisms: DNA-Based Molecular Markers and Their Application in Medicine [Internet]. Genetic Diversity and Disease Susceptibility. InTech; 2018.
TOPORCOV, TN, et al. Consumo de alimentos de origem animal e câncer de boca e orofaringe. Rev Panam Salud Publica. 32(3):185–91. 2012.
VALLE, CN; PASSOS, RMM; GONÇALVES, JTCL; GOMES, C; BASTOS, AMTN; GUEDES, VR. Carcinoma Espinocelular Oral: Um Panorama Atual. Review Article. Rev Pat Tocantins V. 3, n. 04, Sociedade De Patologia Do Tocantins. 2016.
ZHANG, Y., ZHANG, D., ZHAO, L., SUN, L., DONG, Q., CHENG, L., & CHENG, R. Association between p53 Arg72Pro polymorphism and colorectal cancer risk in Asian population: a meta-analysis. Current problems in cancer. 42(6), 582–592. 2018.
ZHOU X, GU Y, ZHANG SL. Association between p53 codon 72 polymorphism and cervical cancer risk among Asians: a HuGE review and meta-analysis. Asian Pac J Cancer Prev. 13(10):4909-4914. 2012.
